COVID-19 has had a catastrophic impact on the most vulnerable communities around the world, which has been threatening decades of progress in the fight against HIV, TB and malaria. The Global Fund works with partners, countries and communities to fight COVID-19, adapt lifesaving HIV, TB and malaria programs, and reinforce fragile systems for health. Through our COVID-19 Response Mechanism (C19RM), the Global Fund has become primary channel for providing grant support to low- and middle-income countries for COVID-19 tests, treatments (including medical oxygen), personal protective equipment (PPE) and critical elements of health system strengthening. C19RM is continuing past the emergency phase for longer-term programs and reinvestments. C19RM investments can be utilized until 31 December 2023, and countries may still continue to implement interventions after this date.

Global Fund support to fight COVID-19:

As of May 2023

  • Total funds approved to support the Global Fund's COVID-19 response: US$5 billion
  • Countries who received Global Fund support for COVID-19: 109 countries and 22 multicountry programs
  • C19RM 2021 funds raised to date: US$4.2 billion
  • Funding Approved for the COVID-19 Response: (Excel | PDF)

* Full list of countries with approved funding is available here. These numbers are only updated once countries have been notified of their funding approval.

How countries are using COVID-19 funding:

As of May 2023

68%: Reinforcing national COVID-19 response: including purchasing critical tests, treatments, oxygen and medical supplies; protecting front-line health workers with training and PPE like gloves and masks; and supporting control and containment interventions, including test, trace and treat/isolate.

18%: Mitigating COVID-19 impact on HIV, TB and malaria programs: including by delivering medicines, mosquito nets and critical supplies door to door, protecting community health workers and providing support and prevention services via digital platforms.

14%: Making urgent improvements to health and community systems to help fight COVID-19, HIV, TB and malaria, including by reinforcing supply chains, laboratory networks and community led response systems.